Linden Advisors’s Sanaby Health Acquisition Corp. I Class A Common Stock SANB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-36,558
Closed -$370K 717
2022
Q3
$370K Sell
36,558
-591,929
-94% -$5.98M ﹤0.01% 446
2022
Q2
$6.31M Hold
628,487
0.06% 197
2022
Q1
$6.29M Buy
628,487
+434,687
+224% +$4.33M 0.04% 289
2021
Q4
$1.93M Buy
+193,800
New +$1.92M 0.01% 445

Linden Advisors's SANB Position: Q4 2022 in Review

Linden Advisors sold out of Sanaby Health Acquisition Corp. I Class A Common Stock (SANB) in Q4 2022, closing a stake of 36,558 shares — an estimated $370K sold.

Linden Advisors first reported a position in SANB in Q4 2021 and held it in 4 quarters. The position peaked at $6.31M in Q2 2022. 0 funds tracked by Wall St. Rank hold SANB as of Q4 2022.

  • Linden Advisors reported no remaining Sanaby Health Acquisition Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Linden Advisors sold 36,558 Sanaby Health Acquisition Corp. I Class A Common Stock shares in Q4 2022, an estimated $370K.
  • Linden Advisors first reported a position in Sanaby Health Acquisition Corp. I Class A Common Stock in Q4 2021 and held it in 4 quarters.
  • Linden Advisors's Sanaby Health Acquisition Corp. I Class A Common Stock position peaked at $6.31M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Sanaby Health Acquisition Corp. I Class A Common Stock as of Q4 2022.

Based on Linden Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.